Senate clears FDA Modernization Act 3.0, aiming to align FDA regulations with nonclinical-testing reforms

The U.S. Senate on Dec. 16 passed the FDA Modernization Act 3.0 (S.355) by unanimous consent, sending legislation to the House that would require the FDA to update its regulations to reflect changes Congress enacted in 2022. The bill instructs HHS, acting through the FDA commissioner, to publish an interim final rule no later than… The post Senate clears FDA Modernization Act 3.0, aiming to align FDA regulations with nonclinical-testing reforms appeared first on Drug Discovery and Development.

Continue reading →